
TSI GROUP CO., LTD. — Investor Relations & Filings
TSI Group Co., Ltd. is a global developer and manufacturer of functional ingredients and finished dosage forms for the dietary supplement, pharmaceutical, and food and beverage sectors. The company specializes in the research, development, and large-scale production of high-quality bioactive compounds. Key product categories include joint health ingredients such as glucosamine and chondroitin, as well as proprietary muscle health and metabolic health solutions like HMB and PEAK ATP. TSI Group maintains advanced manufacturing facilities and quality control systems to ensure compliance with international standards. The organization focuses on providing science-based ingredients supported by clinical research to global brand owners and manufacturers. Its core capabilities span from raw material sourcing and chemical synthesis to specialized formulation and finished product manufacturing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-06-02 | Chinese | |
| 技源集团股份有限公司股份回购进展公告 | 2026-06-01 | Chinese | |
| 国浩律师(上海)事务所关于技源集团股份有限公司2025年年度股东会的法律意见书 | 2026-05-29 | Chinese | |
| 技源集团股份有限公司2025年年度股东会决议公告 | 2026-05-29 | Chinese | |
| 技源集团股份有限公司关于高级管理人员辞职的公告 | 2026-05-26 | Chinese | |
| 技源集团股份有限公司2025年年度股东会会议资料 | 2026-05-22 | Chinese |
Browse filings by year
2 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47941430 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-06-02 | Chinese | ||
| 47926416 | 技源集团股份有限公司股份回购进展公告 | 2026-06-01 | Chinese | ||
| 47897561 | 国浩律师(上海)事务所关于技源集团股份有限公司2025年年度股东会的法律意见书 | 2026-05-29 | Chinese | ||
| 47896781 | 技源集团股份有限公司2025年年度股东会决议公告 | 2026-05-29 | Chinese | ||
| 47077410 | 技源集团股份有限公司关于高级管理人员辞职的公告 | 2026-05-26 | Chinese | ||
| 46868153 | 技源集团股份有限公司2025年年度股东会会议资料 | 2026-05-22 | Chinese | ||
| 46364759 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-15 | Chinese | ||
| 45016886 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-11 | Chinese | ||
| 44267612 | 技源集团股份有限公司关于回购股份事项前十大股东和前十大无限售条件股东持股情况的报告 | 2026-05-07 | Chinese | ||
| 44267577 | 技源集团股份有限公司关于使用闲置募集资金进行现金管理赎回的公告 | 2026-05-07 | Chinese | ||
| 39593617 | 技源集团2025年度报告摘要 | 2026-04-27 | Chinese | ||
| 39593616 | 东方证券股份有限公司关于技源集团股份有限公司2025年度日常关联交易执行情况和2026年度日常关联交易预计的核查意见 | 2026-04-27 | Chinese | ||
| 39593612 | 技源集团关于使用部分闲置募集资金进行现金管理的公告 | 2026-04-27 | Chinese | ||
| 39593607 | 技源集团2025年度董事会审计委员会履职报告 | 2026-04-27 | Chinese | ||
| 39593602 | 技源集团关于2026年第一季度主要经营数据公告 | 2026-04-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Hangzhou Tianmushan Pharmaceutical Enterprise Co.,Ltd
Produces TCM, chemical drugs, and health supplements for di…
|
600671 | CN | Manufacturing |
|
Hanmi Pharm. Co., Ltd.
A research-oriented biopharmaceutical company developing an…
|
128940 | KR | Manufacturing |
|
Hanmi Science Co.,Ltd
A holding company managing subsidiaries in the pharmaceutic…
|
008930 | KR | Manufacturing |
|
Hansa Biopharma
Develops antibody-cleaving enzyme technology for rare immun…
|
HNSA | SE | Manufacturing |
|
Hansoh Pharmaceutical Group Company Limited
Leading innovation-driven biopharmaceutical enterprise deve…
|
3692 | KY | Manufacturing |
|
Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
Clinical-stage biopharma developing immuno-oncology therapi…
|
3378 | HK | Manufacturing |
|
Harbin Fuerjia Technology Co., Ltd.
Develops medical dressings and functional cosmetics for ski…
|
301371 | CN | Manufacturing |
|
HARBIN GLORIA PHARMACEUTICALS Co., LTD
Develops and produces drugs for cardiovascular, orthopedic,…
|
002437 | CN | Manufacturing |
|
HARBIN MEDISAN PHARMACEUTICAL CO.,LTD.
Produces injections and oral drugs for cardiovascular, gast…
|
002900 | CN | Manufacturing |
|
Harbin Pharmaceutical Group Co.,Ltd.
Researches and manufactures pharmaceuticals, OTC drugs, and…
|
600664 | CN | Manufacturing |
TSI GROUP CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57547/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57547 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57547 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57547 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57547}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TSI GROUP CO., LTD. (id: 57547)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.